Zhitong Finance App News, Buchang Pharmaceutical (603858.SH) announced that in order to enrich the company's product development pipeline, the company's holding subsidiary Zhejiang Tianyuan Biopharmaceutical Co., Ltd. (hereinafter referred to as “Zhejiang Tianyuan”) plans to cooperate with Fubicheng (Shanghai) Pharmaceutical Technology Co., Ltd. (hereinafter referred to as “Fubicheng Pharmaceutical”) and sign a “Entrusted R&D Agreement” on MF59 emulsion adjuvants.

Zhitongcaijing · 05/20 09:33
Zhitong Finance App News, Buchang Pharmaceutical (603858.SH) announced that in order to enrich the company's product development pipeline, the company's holding subsidiary Zhejiang Tianyuan Biopharmaceutical Co., Ltd. (hereinafter referred to as “Zhejiang Tianyuan”) plans to cooperate with Fubicheng (Shanghai) Pharmaceutical Technology Co., Ltd. (hereinafter referred to as “Fubicheng Pharmaceutical”) and sign a “Entrusted R&D Agreement” on MF59 emulsion adjuvants.